Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients

Neurobiology of Disease

Volumn 5, Issue 1, 1998, Pages 55-64

  Rosenbaum, C ^a   Kluwe, L ^b   Mautner, V F ^c   Friedrich, R E ^b   Muller H W ^a   Hanemann, C O ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Klinik Ochsenzoll   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; LINK PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CONTACT INHIBITION; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MUTATION; NERVE CELL CULTURE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHWANN CELL;

EID: 0032127257     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1998.0179     Document Type: Article

References (43)

1. Antinheimo J., Haapasalo H., Seppälä M., Sainio M., Carpen O., Jääskeläinen J. Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studies by MIB-1 (Ki-67) and PCNA labeling. J. Neuropathol. Exp. Neurol. 54:1995;776-782.
2. Den Bakker M. A., Tascilar M., Riegman P. H. J., Hekman A. C. P., Boersma W., Janssen P. J. A., deJong T. A. W., Hendriks W., van der Kwast T. H., Zwarthoff E. C. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am. J. Pathol. 147:1995;1339-1349.
3. Bollensen E., Scheidt P., Schachner M. Production and characterisation of monoclonal antibodies to the major peripheral myelin protein P0. J. Neurochem. 54:1990;1110-1114.
4. Bosse F., Zoidl G., Wilms S., Gillen C. P., Kuhn H. G., Müller H. W. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J. Neurosci. Res. 37:1994;529-537.
5. Bottenstein J., Sato G. H. Growth of a neuroblastoma cell line in serum free supplemented medium. Proc. Natl. Acad. Sci. USA. 76:1979;514-517.
6. Bretscher A. Purification of an 80.000d protein that is a component of the isolated microvillus cytoskeleton, and its localisation in nonmuscle cells. J. Cell. Biol. 97:1983;425-432.
7. Deguen B., Merel P., Goutebroze L., Giovannini M., Reggio H., Arpi L., Thomas G. Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane. Hum. Mol. Genet. 7:1998;217-226.
8. Gonzalez-Agosti C., Xu L., Pinney D., Beauchamp R., Hobbs W., Gusella J., Ramesh V. The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene. 13:1996;1239-1247.
9. Hanemann C. O., Rosenbaum C., Kupfer S., Wosch S., Stoegbauer F., Müller H-W. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia. 23:1998;89-98.
10. Henry M. D., Gonzalez-Agosti C., Solomon F. Molecular dissection of radixin: Distinct and interdependent functions of the amino- and carboxy-terminal domains. J. Cell. Biol. 129:1995;1007-1022.
11. Huynh D. P., Pulst S-M. Neurofibromatosis 2 antisense oligonucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene. 13:1996;73-84.
12. Jacoby L. B., MacCollin M., Louis D. N., Mohney T., Rubio M-P., Pulaski K., Trofatter J. A., Kley N., Seizinger B., Ramesh V., Gusella J. F. Exon scanning for mutation of theNF2. Hum. Mol. Genet. 3:1994;413-419.
13. Jacoby L. B., MacCollin M., Barone R., Ramesh V., Gusella J. F. Frequency and distribution ofNF2. Genes Chromosomes Cancer. 17:1996;45-55.
14. ras. Oncogene. 11:1995;325-335.
15. Kluwe L., Bayer S., Baser M. E., Hazim W., Haase W., Fünfterer C., Mautner V. F. Identification ofNF2. Hum. Genet. 98:1996;534-538.
16. Levi A. D. O., Bunge R. P., Lofgren J. A., Meima L., Hefti F., Nikolics K., Sliwkowski M. J. The influence of heregulins on human Schwann cell proliferation. J. Neurosci. 15:1995;1329-1340.
17. Lutchman M., Rouleau G. A. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res. 55:1995;2270-2274.
18. Morrissey T. K., Bunge R. P., Kleitman N. Human Schwann cells in vitro. I. Failure to differentiate and support neuronal health under co-culture conditions that promote full function of rodent cells. J. Neurobiol. 28:1995;171-189.
19. Arch. Neurol. 45:1988;575-578.
20. Parry D. M., MacCollin M. M., Kaiser-Kupfer M. I., Pulaski K., Nicholson H. S., Bolesta M., Eldridge R., Gusella J. F. Germ-line mutations in the neurofibromatosis 2 gene: Correlations with the disease severity and retinal abnormalities. Am. J. Hum. Genet. 59:1996;529-539.
21. Rouleau G. R., Seizinger B. R., Superneau D. W., Conneally P. M., Gusella J. F. Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DANN marker on chromosome 22. Nature. 329:1987;246-248.
22. Rouleau G. A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B., Pulst S. M., Lenoir G., Bijlsma E., Fashold R., Dumanski J., deJong P., Parry D., Eldrige R., Aurias A., Delattre O., Thomas G. Alteration in a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature. 363:1993;515-521.
23. Rubinfeld B., Souza B., Albert I., Müller O., Chamberlain S. H., Masiarz F. R., Munemitsu S., Polakis P. Association of the APC gene product with β-catenin. Science. 262:1993;1731-1733.
24. Rutkowski J. L., Kirk C. J., Lerner M. A., Tennekoon G. I. Purification and expansion of human Schwann cellsin vitro. Nature Med. 1:1995;80-83.
25. Ruttledge M. H., Andermann A. A., Phelan C. M., Claudio J. O., Han F. Y., Chretien N., Rangaratnam S., MacCollin M., Short P., Parry D., Michels V., Riccardi V. M., Weksberg R., Kitamura K., Bradburn J. M., Hall B. D., Propping P., Rouleau G. A. Type of mutations in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am. J. Hum. Genet. 59:1996;331-342.
26. Sainz J., Huynh D. P., Figueroa K., Ragge N. K., Baser M. B., Pulst S. M. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet. 3:1994;885-891.
27. Sato N., Yonemura S., Obinata T., Tsukita S., Tsukita S. Radixin, a barbed end-capping actin-modulating protein, is concentrated in the cleavage furrow during cytokinesis. J. Cell. Biol. 113:1991;321-330.
28. Scherer S. S., Gutmann D. H. Expression of the neurofibromatosis 2 tumor suppressor gene product, Merlin, in Schwann cells. J. Neurosci. Res. 46:1996;595-605.
29. Schmucker B., Ballhausen W. G., Kressel M. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin. Eur. J. Cell Biol. 72:1997;46-53.
30. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., St George-Hyslop P., Huson S., Gusella J. F., Martuza R. L. A common pathogenetic mechanism for the three tumor types in bilateral acoustic neurofibromatosis. Science. 236:1987a;317-319.
31. Seizinger B. R., de la Monte S., Atkins L., Gusella J. F., Martuza R. L. Molecular genetic approach to human meningioma: Loss of genes on chromosome 22. Proc. Natl. Acad. Sci. USA. 84:1987b;5419-5423.
32. Sherman L., Jacoby L. B., Lampe J., Pelton P., Aguzzi A., Herrlich P. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Cancer Res. 57:1997;4889-4897.
33. Su L-K., Vogelstein B., Kinzler K. W. Association of the APC tumor suppressor protein with catenins. Science. 262:1993;1734-1737.
34. Takeshima H., Izawa I., Lee P. S. Y., Safdar N., Levin V. A., Saya H. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene. 9:1994;2135-2144.
35. Takeuchi K., Sato N., Kasahara H., Funayama N., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J. Cell Biol. 125:1994;1371-1384.
36. Tikoo A., Varga M., Ramesh V., Gusella J., Maruta H. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J. Biol. Chem. 269:1994;23387-22339.
37. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Nenon A. G., Pulaski K., Haase V. H., Ambrose C. M., Munroe D., Bove C., Haines J., Martuza R. L., MacDonald M. E., Seizinger B. R., Short M. P., Buckler A. J., Gusella J. F. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 72:1993;791-800.
38. Tsukita S., Tsukita S., Nagafuchi A., Yonemura S. Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr. Biol. 4:1992;834-839.
39. Turunen O., Wahlström T., Vaheri A. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J. Cell. Biol. 126:1994;1445-1453.
40. Twist E., Ruttledge M. H., Rousseau M., Sanson M., Papi L., Merel P., Delattre O., Thomas G., Rouleau G. A. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum. Mol. Genet. 3:1994;147-151.
41. De Vitis L. R., Tedde A., Vitelli F., Ammannati F., Mennonna P., Bigozzi U., Montali E., Papi L. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum. Genet. 97:1996;632-637.
42. Wellenreuther R., Kraus J. A., Lenartz D., Menon A. G., Schramm J., Louis D. N., Ramesh V., Gusella J. F., Wiestler O. D., von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am. J. Pathol. 146:1995;827-832.
43. Xu H. M., Gutmann D. H. Merlin differentially associates with the microtubule and actin cytoskeleton. J. Neurosci. Res. 51:1998;403-415.